PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28538998
OWN - NLM
STAT- MEDLINE
DA  - 20170524
DCOM- 20170706
LR  - 20170706
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 317
IP  - 22
DP  - 2017 Jun 13
TI  - More Treatments on Deck for Alcohol Use Disorder.
PG  - 2267-2269
LID - 10.1001/jama.2017.4760 [doi]
FAU - Lyon, Jeff
AU  - Lyon J
LA  - eng
PT  - Journal Article
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
RN  - 0 (Alcohol Deterrents)
RN  - 0 (Amines)
RN  - 0 (Cyclohexanecarboxylic Acids)
RN  - 0H73WJJ391 (topiramate)
RN  - 1EQV5MLY3D (Taurine)
RN  - 30237-26-4 (Fructose)
RN  - 320T6RNW1F (Mifepristone)
RN  - 536BQ2JVC7 (Cytidine Diphosphate Choline)
RN  - 56-12-2 (gamma-Aminobutyric Acid)
RN  - 5S6W795CQM (Naltrexone)
RN  - 6CW7F3G59X (gabapentin)
RN  - H789N3FKE8 (Baclofen)
RN  - N4K14YGM3J (acamprosate)
RN  - TOV02TDP9I (nalmefene)
RN  - TR3MLJ1UAI (Disulfiram)
RN  - W6HS99O8ZO (Varenicline)
SB  - AIM
SB  - IM
MH  - Alcohol Deterrents/*therapeutic use
MH  - Alcohol-Related Disorders/*drug therapy/epidemiology
MH  - Amines/therapeutic use
MH  - Baclofen/therapeutic use
MH  - Cyclohexanecarboxylic Acids/therapeutic use
MH  - Cytidine Diphosphate Choline/therapeutic use
MH  - Disulfiram/therapeutic use
MH  - Drug Repositioning
MH  - Fructose/analogs & derivatives/therapeutic use
MH  - Humans
MH  - Mifepristone/therapeutic use
MH  - Naltrexone/analogs & derivatives/therapeutic use
MH  - National Institute on Alcohol Abuse and Alcoholism (U.S.)
MH  - Off-Label Use
MH  - Patient Acceptance of Health Care/statistics & numerical data
MH  - Taurine/analogs & derivatives/therapeutic use
MH  - United States
MH  - Varenicline/therapeutic use
MH  - gamma-Aminobutyric Acid/therapeutic use
EDAT- 2017/05/26 06:00
MHDA- 2017/07/07 06:00
CRDT- 2017/05/25 06:00
AID - 2629516 [pii]
AID - 10.1001/jama.2017.4760 [doi]
PST - ppublish
SO  - JAMA. 2017 Jun 13;317(22):2267-2269. doi: 10.1001/jama.2017.4760.